Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
funding
Biotech
Cour inks $940M-plus autoimmune deal with Roche's Genentech
Chicago’s Cour Pharmaceuticals is bringing its immunology mission to the fore with a new deal featuring Swiss drug juggernaut Roche.
Fraiser Kansteiner
Dec 3, 2024 7:58am
Life science credit firm unveils with $600M
Aug 6, 2024 10:30am
Accelus picks up $20M to expand spine implant tech
Jan 22, 2024 12:02pm
48% of biotechs relying on Big Pharma for funding: ICON survey
Dec 18, 2023 9:00am
Cure Ventures unveils inaugural $350M fund
Apr 4, 2023 7:00am
Novo, Medtronic join heart sensor maker FIRE1’s $25M funding
Mar 15, 2023 1:17pm